Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 3001 results

Press release / Feb 11, 2025

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…
Building belonging
Events
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building from the main gate, Novartis Campus Basel (vertical)
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building from Park South, Novartis Campus Basel (vertical)
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building, Novartis Campus Basel (vertical)
Media Library / Oct 23, 2023

Novartis logo on the Banting 1 building, Novartis Campus Basel (horizontal)
Media Library / Oct 23, 2023

Novartis logo through the colorful facade of Forum 3, Novartis Campus Basel (vertical)

‹ Previous page
1
…
58
59
60
61
62
63
64
…
301
› Next page